Guest Article
Cognitive and memory warning letters and litigation trends: Best practices for reducing risk
Cognition and memory products are big business, and the Food and Drug Administration (FDA), National Advertising Division (NAD), Federal Trade Commission (FTC) and plaintiff attorneys are paying attention.